blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP0861266

EP0861266 - PEPTIDE CONJUGATES DERIVED FROM THYMIC HORMONES, THEIR USE AS MEDICAMENT AND COMPOSITIONS CONTAINING THEM [Right-click to bookmark this link]
StatusThe patent has been limited
Status updated on  06.03.2009
Database last updated on 19.10.2024
Most recent event   Tooltip06.03.2009(Expected) limited patent specificationpublished on 08.04.2009  [2009/15]
Applicant(s)For all designated states
INSTITUT EUROPEEN DE BIOLOGIE CELLULAIRE
18, avenue de l'Europe
31520 Ramonville Saint-Agne / FR
[2009/15]
Former [1998/36]For all designated states
INSTITUT EUROPEEN DE BIOLOGIE CELLULAIRE
18, avenue de l'Europe
F-31520 Ramonville-Saint-Agne / FR
Inventor(s)01 / DUSSOURD D'HINTERLAND, Lucien
10, rue Pierre-Benoît
F-31400 Toulouse / FR
02 / PINEL, Anne-Marie
771, rue des Navigateurs
F-34280 La Grande-Motte / FR
[1998/36]
Representative(s)Warcoin, Jacques, et al
Cabinet Regimbeau
20, rue de Chazelles
75847 Paris Cedex 17 / FR
[N/P]
Former [1998/36]Warcoin, Jacques, et al
Cabinet Régimbeau, 26, avenue Kléber
75116 Paris / FR
Application number, filing date96939132.515.11.1996
[1998/36]
WO1996FR01812
Priority number, dateFR1995001354415.11.1995         Original published format: FR 9513544
[1998/36]
Filing languageFR
Procedural languageFR
PublicationType: A1 Application with search report
No.:WO9718239
Date:22.05.1997
Language:FR
[1997/22]
Type: A1 Application with search report 
No.:EP0861266
Date:02.09.1998
Language:FR
The application published by WIPO in one of the EPO official languages on 22.05.1997 takes the place of the publication of the European patent application.
[1998/36]
Type: B1 Patent specification 
No.:EP0861266
Date:23.04.2003
Language:FR
[2003/17]
Type: B3 Limited patent 
No.:EP0861266
Date:08.04.2009
Language:FR
[2009/15]
Search report(s)International search report - published on:EP22.05.1997
ClassificationIPC:C07K14/66, C07K7/06, A61K38/04
[1998/36]
CPC:
A61K8/64 (EP,US); A61K8/36 (EP,US); A61K8/362 (EP,US);
A61K8/4986 (EP,US); A61P17/00 (EP); A61P17/14 (EP);
A61P37/00 (EP); A61P37/02 (EP); A61Q19/08 (EP,US);
A61Q7/00 (EP,US); C07K14/66 (EP,US); C07K7/062 (EP,US);
A61K2800/57 (EP,US); A61K38/00 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1998/36]
TitleGerman:AUS THYMISCHEN HORMONEN ABSTAMMENDE PEPTID KONJUGIERTE, DEREN VERWENDUNG ALS MEDIKAMENTE UND AUS DEREN ENTHALTENDE ZUSAMMENSETZUNGEN[1998/36]
English:PEPTIDE CONJUGATES DERIVED FROM THYMIC HORMONES, THEIR USE AS MEDICAMENT AND COMPOSITIONS CONTAINING THEM[1998/36]
French:CONJUGUES PEPTIDIQUES DERIVES DES HORMONES THYMIQUES, LEUR UTILISATION A TITRE DE MEDICAMENT ET COMPOSITIONS LES CONTENANT[1998/36]
Entry into regional phase12.06.1998National basic fee paid 
12.06.1998Designation fee(s) paid 
12.06.1998Examination fee paid 
Examination procedure13.06.1997Request for preliminary examination filed
International Preliminary Examining Authority: EP
12.06.1998Examination requested  [1998/36]
25.01.2002Despatch of a communication from the examining division (Time limit: M04)
25.04.2002Reply to a communication from the examining division
18.10.2002Communication of intention to grant the patent
17.02.2003Fee for grant paid
17.02.2003Fee for publishing/printing paid
Opposition(s)26.01.2004No opposition filed within time limit [2004/16]
Limitations:19.12.2007Date of receipt of request for limitation
 admissible
19.01.2009Communication of intention to limit the patent
23.02.2009Fee for printing patent specification after limitation
30.09.2008Despatch of a communication from the examining division (Time limit: M02)
24.11.2008Reply to a communication from the examining division
Fees paidRenewal fee
23.11.1998Renewal fee patent year 03
29.11.1999Renewal fee patent year 04
20.11.2000Renewal fee patent year 05
26.11.2001Renewal fee patent year 06
25.11.2002Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT23.04.2003
FI23.04.2003
IE23.04.2003
NL23.04.2003
DK23.07.2003
GR23.07.2003
PT23.07.2003
SE23.07.2003
LU15.11.2003
BE30.11.2003
MC30.11.2003
[2007/04]
Former [2005/02]AT23.04.2003
FI23.04.2003
NL23.04.2003
DK23.07.2003
GR23.07.2003
PT23.07.2003
SE23.07.2003
LU15.11.2003
BE30.11.2003
MC30.11.2003
Former [2005/01]AT23.04.2003
FI23.04.2003
NL23.04.2003
DK23.07.2003
GR23.07.2003
PT23.07.2003
SE23.07.2003
LU15.11.2003
BE30.11.2003
Former [2004/39]AT23.04.2003
FI23.04.2003
NL23.04.2003
DK23.07.2003
GR23.07.2003
PT23.07.2003
SE23.07.2003
LU15.11.2003
Former [2004/23]AT23.04.2003
FI23.04.2003
NL23.04.2003
DK23.07.2003
GR23.07.2003
PT23.07.2003
SE23.07.2003
Former [2004/05]AT23.04.2003
FI23.04.2003
NL23.04.2003
GR23.07.2003
PT23.07.2003
SE23.07.2003
Former [2004/03]AT23.04.2003
NL23.04.2003
GR23.07.2003
PT23.07.2003
SE23.07.2003
Former [2004/02]NL23.04.2003
GR23.07.2003
PT23.07.2003
SE23.07.2003
Former [2004/01]NL23.04.2003
PT23.07.2003
SE23.07.2003
Former [2003/41]SE23.07.2003
Cited inInternational search[X]FR2411174  (ORTHO PHARMA CORP [US]) [X] 1,2,4-9,12-26 * examples 8,12 *;
 JPS6089499  [ ] (MITSUI SEIYAKU KOGYO KK);
 [X]EP0166612  (ORTHO PHARMA CORP [US]) [X] 1,2,4-9,12-26 * column W *;
 [X]  - J ODARJUK ET AL., "Histamine-releasing activity as an undesired side-effect in the development of peptide analogs", CHEMICAL ABSTRACTS, (19950102), vol. 122, no. 1, Database accession no. 1237g, page 147, XP002010397 [X] 1,2,4-9,12-26 * abstract *
    [ ] - CHEM. PEPT. PROTEINS, (1993), vol. 5/6 (Pt. A), pages 475 - 482
 [X]  - G A HEAVNER ET AL., "Peptide analogs of thymopentin distinguish distinct thymopoietin receptor specificities on two human T cell lines", REGULATORY PEPTIDES, AMSTERDAM, THE NETHERLANDS, (1990), vol. 27, pages 257 - 262, XP000646225 [X] 1,2,4-9,12-26 * table I *

DOI:   http://dx.doi.org/10.1016/0167-0115(90)90044-W
 [X]  - G A HEAVNER ET AL., "Biologically active analogs of thymopentin with enhanced enzymatic stability", PEPTIDES, FAYETTEVILLE, USA, (198612), vol. 7, no. 6, pages 1015 - 1019, XP000646219 [X] 1,2,4-9,12-26 * table 1 *

DOI:   http://dx.doi.org/10.1016/0196-9781(86)90131-2
 [A]  - "Peptides for radioimmunoassay of serum thymic factor", CHEMICAL ABSTRACTS, (19860120), vol. 104, no. 3, Database accession no. 19826, XP002027989 [A] 1,2,4-9,21-26 * abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.